Bio International Convention 2023
Boston, United States June 5-8, 2023
Rx Propellant is attending BIO 2023
Rx Propellant is thrilled to be a part of BIO 2023, the world’s largest biotechnology conference, in Boston from June 5 through June 8 at the Boston Convention & Exhibition Center in the USA. This annual convention attracts 14,000+ biotechnology and pharma leaders on a wide spectrum of life sciences and applications, including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy.
We invite you to join us at this year’s India Pavilion, led by ABLE (Association of Biotechnology Led Enterprises), India. We are excited to meet with you and learn about your infrastructure needs as you prepare to scale your operations in the Asia Pacific region.
See you at Booth #3545.
Rx Propellant becomes a part of the Actis portfolio
Rx Propellant has been acquired by Actis – a UK based global investment company for an initial USD 200 million investment in May 2022. This investment places a focus on sustainability in life science clusters in the cities of Hyderabad, Bengaluru and Mumbai.
Rx Propellant announces the launch of 9 lakh sqft of lab spaces in Hyderabad
Hyderabad, October 18, 2022: India’s leading life sciences infrastructure and cluster developers, Rx Propellant, on Tuesday announced the launch of 9 lakh sqft of lab spaces in Genome Valley of Hyderabad. The foundation stones for two new projects, B-hub and GV1, were laid by Industries & Commerce Minister K.T. Rama Rao.
Meeting to boost collaboration in life sciences held in Hyderabad
Hyderabad, February 23, 2023: A meeting seeking to promote collaboration in life sciences and serve as a networking platform for researchers, entrepreneurs and industry professionals was conducted on Thursday at Genome Valley.
Rx Propellant, Roach Lifescapes to set up life sciences cluster in Bengaluru
Bengaluru, March 15, 2023: Rx Propellant in partnership with Roach Lifescapes, plans to set up a 52-acre campus, Bengaluru Lifesciences Research (BLR) District, in Attibele, Bengaluru. The project comprises lab space modules and built-to-suit flexi factories catering to the biopharma, medtech, agriscience, nutraceutical, and allied sectors.